PartnerRe Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-10,893
Closed -$622K 8
2016
Q1
$622K Sell
10,893
-200
-2% -$11.1K 0.32% 49
2015
Q4
$657K Sell
11,093
-18,864
-63% -$1.09M 0.34% 46
2015
Q3
$1.63M Sell
29,957
-1,104
-4% -$71.9K 0.28% 57
2015
Q2
$2.09M Sell
31,061
-2,709
-8% -$177K 0.39% 52
2015
Q1
$1.98M Sell
33,770
-162
-0.5% -$9.79K 0.33% 61
2014
Q4
$2.22M Buy
33,932
+4,801
+16% +$303K 0.36% 53
2014
Q3
$1.68M Sell
29,131
-4,678
-14% -$260K 0.33% 57
2014
Q2
$1.91M Sell
33,809
-4,581
-12% -$240K 0.34% 55
2014
Q1
$1.97M Buy
38,390
+95
+0.2% +$4.8K 0.33% 61
2013
Q4
$2.02M Sell
38,295
-2,113
-5% -$104K 0.35% 61
2013
Q3
$1.81M Sell
40,408
-5,289
-12% -$234K 0.3% 63
2013
Q2
$1.89M Buy
+45,697
New +$2M 0.31% 66

Other funds holding ABBV

PartnerRe Asset Management's ABBV Position: Q2 2016 in Review

PartnerRe Asset Management sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 10,893 shares — an estimated $622K sold.

PartnerRe Asset Management first reported a position in ABBV in Q2 2013 and held it in 12 quarters. The position peaked at $2.22M in Q4 2014. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • PartnerRe Asset Management reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 10,893 AbbVie shares in Q2 2016, an estimated $622K.
  • PartnerRe Asset Management first reported a position in AbbVie in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's AbbVie position peaked at $2.22M in Q4 2014.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.